Skip to main content

Table 3 Percentage gene expression of mEC-specific genes expressed in primary versus recurrent tumor samples (Group A expressed similarly in primary and recurrent samples).

From: Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples

 

% Gene Expression

 

% Gene Expression

Gene Name

Tumor

SCC-PSA1

Gene Name

Tumor

Nulli-SCC

 

(P/R)

(U/D)

 

(P/R)

(U/D)

Group A

  

Group A

  

Dusp26

 

325.2

Egln3

 

259.9

Hsf2

 

222.5

Ndufab1

 

245.4

Pdzk1

 

212.8

Gpr6

 

229.6

Sdsl

 

226.2

Ltbr

 

212.2

Ndufs6

 

-203.1

Golga5

 

-208.5

Sox4

 

-208.1

Slc15a1

 

-214.6

Group B

  

Gpatc3

 

-236.7

Itgbl1

432.6

-396.1

Dgcr8

 

-323.3

Kcnmb4

397.0

267.5

Tirap

 

-364.3

Nkx3-1

375.2

260.0

Group B

  

Tmprss2

368.3

373.0

Cask

442.1

-220.5

Cthrc1

334.6

298.7

Stau2

292.9

-201.6

Pdgfc

283.2

-392.8

Bnip3

283.4

217.4

Plaur

259.9

-263.2

Pfkp

239.4

251.0

Hoxb2

239.3

-375.5

Pak6

202.4

-213.8

Col4a5

210.8

-320.7

   

Gata2

-276.5

-243.0

  Â